Achilles Therapeutics Plc (ACHL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 18,460 | 15,738 | 16,289 | 13,708 | 12,919 |
Operating Income | -18,460 | -15,738 | -16,289 | -13,708 | -12,919 |
Other Income | 226 | 2,806 | 146 | -45 | 2 |
Pre-tax Income | -18,234 | -12,932 | -16,143 | -13,753 | -12,917 |
Income Tax | 9 | 16 | N/A | 12 | 3 |
Net Income Continuous | -18,230 | -12,948 | -16,156 | -13,765 | -12,920 |
Net Income | $-18,230 | $-12,948 | $-16,156 | $-13,765 | $-12,920 |
EPS Basic Total Ops | 7.04 | -0.34 | -0.45 | -8.38 | -9.87 |
EPS Basic Continuous Ops | 7.04 | -0.34 | -0.45 | -8.38 | -9.87 |
EPS Diluted Total Ops | 7.04 | -0.34 | -0.45 | -8.38 | -9.87 |
EPS Diluted Continuous Ops | 7.04 | -0.34 | -0.45 | -8.38 | -9.87 |
EBITDA(a) | $-17,623 | $-14,906 | $-15,459 | $-12,919 | $-12,520 |